PharmaCyte Biotech, Inc.
- PMCB
- NASDAQ
- Biotechnology
- Cell Therapy (Cell-in-a-Box)
- Cancer/Diabetes Therapies
$0.34
Today +0.53%Quote Oct 19, 2026, 08:00 PM UTC
−25.60%over the last month
Max drawdown −26.0%From 1-month high −25.6%3 months −43.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About PharmaCyte Biotech
PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
2
Market value
$3.7M
Quote Oct 19
Floor
$0.34
0.6% below price
Resistance
$0.36
4.9% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about PMCBPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free